Hemostatic Outcomes of Hip and Knee Joint Replacement Surgery in Von Willebrand Disease (VWD) Patients: A Single Center Study

被引：0
|
作者：
Pruthi, Rajiv [1 ]
Nichols, William L., Jr. [2 ]
Rugeri, Lucia [3 ]
机构：
[1] Mayo Clin, Mayo Comprehens Hemophilia Ctr, Rochester, MN USA
[2] Mayo Clin, Special Coagulat Lab, Rochester, MN USA
[3] Hop Edouard Herriot, Unite Hemostase, Lyon, France
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：989 / 989
页数：1
相关论文
共 50 条
  • [41] Evaluation of the effect on endogenous factor VIII activity (FVIII: C) after recombinant von Willebrand factor (rVWF) administration during the elective surgery study in patients with severe von Willebrand disease (VWD)
    Mamaev, Andrey
    Wang, Jiaan-Der
    vonAuer, Charis Anna Maria
    Stasyshyn, Oleksandra
    Timofeeva, Margarita
    Curry, Nicola
    Rosa Cid, Ana
    Yee, Thynn Thynn
    Kavakli, Kaan
    Peyvandi, Flora
    HAEMOPHILIA, 2018, 24 : 107 - 108
  • [42] Perceptions of Physician Recommendations for Joint Replacement Surgery in Older Patients with Severe Hip or Knee Osteoarthritis
    Schonberg, Mara A.
    Marcantonio, Edward R.
    Hamel, Mary Beth
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 (01) : 82 - 88
  • [43] Preparation of patients for hip or knee replacement surgery as an important element in preventing periprosthetic joint infection
    Bialecki, Jerzy
    Brychcy, Adrian
    Marczynski, Wojciech
    PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2015, 11 (02): : 205 - 209
  • [44] A COMPARISON OF CHARACTERISTICS OF PATIENTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE WILLING OR NOT TO UNDERGO TOTAL JOINT REPLACEMENT SURGERY
    Conaghan, P. G.
    Abraham, L.
    Viktrup, L.
    Cappelleri, J.
    Beck, C. G.
    Bushmakin, A. G.
    Jackson, J.
    Berry, M.
    Jackson, J.
    VALUE IN HEALTH, 2020, 23 : S603 - S603
  • [45] Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee
    Fortin, PR
    Penrod, JR
    Clarke, AE
    St-Pierre, Y
    Joseph, L
    Bélisle, P
    Liang, MH
    Ferland, D
    Phillips, CB
    Mahomed, N
    Tanzer, M
    Sledge, C
    Fossel, AH
    Katz, JN
    ARTHRITIS AND RHEUMATISM, 2002, 46 (12): : 3327 - 3330
  • [46] The effect of drug treatment on functional outcomes of hip and knee joint replacement in patients with rheumatoid arthritis
    Herasymenko, S., I
    Huzhevskyi, I., V
    Poluliakh, M., V
    Babko, A. M.
    ZAPOROZHYE MEDICAL JOURNAL, 2021, 23 (01) : 83 - 89
  • [47] Pregnancy loss in women with von Willebrand disease: a single-center pilot study
    Skeith, Leslie
    Rydz, Natalia
    O'Beirne, Maeve
    Goodyear, Dawn
    Li, Haocheng
    Poon, Man-Chiu
    BLOOD COAGULATION & FIBRINOLYSIS, 2017, 28 (05) : 393 - 397
  • [48] OUTCOMES AFTER JOINT REPLACEMENT SURGERY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Gregory, Martin H.
    McKinnon, Andrew
    Stwalley, Dustin
    Loftus, Edward V.
    Hippensteel, K. J.
    Ciorba, Matthew A.
    Olsen, Margaret A.
    Deepak, Parakkal
    GASTROENTEROLOGY, 2018, 154 (06) : S401 - S402
  • [49] Analysis of joint bleeding events from a phase 3, multicenter, open-label study of on-demand recombinant von Willebrand factor (VWF) treatment in patients with severe von Willebrand disease (VWD)
    Windyga, J.
    Chojnowski, K.
    Pasi, J.
    Ploder, B.
    Mital, A.
    Berthoz, F. Truong
    Ewenstein, B.
    Mellgard, B.
    HAEMOPHILIA, 2019, 25 : 112 - 113
  • [50] Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD): reply to a rebuttal
    Budde, U.
    Federici, A. B.
    Goodeve, A.
    Eikenboom, J.
    Schneppenheim, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (11) : 2002 - 2003
12345